{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T21:53:23Z","timestamp":1788386003146,"version":"build-2803163510"},"reference-count":45,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2024,1,10]],"date-time":"2024-01-10T00:00:00Z","timestamp":1704844800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Universidad de Ja\u00e9n"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>We comprehensively evaluated the expression of therapeutically targetable immune checkpoint molecules involved in celiac disease (CD). We have focused on the alteration of the CD200\/CD200R pathway and Elafin expression in celiac disease and discussed their roles in regulating the immune response. There are limited data related to the expression or function of these molecules in celiac disease. This finding could significantly contribute to the understanding of the clinical manifestation of CD. CD200, CD200R and Elafin distributions were determined by ELISA and immunohistochemistry analyses in serum and biopsies of CD patients. Analyses of Th1 and Th17 cytokines were determined. PCR amplification of a fragment of the PI3 gene was carried out using genomic DNA isolated from whole blood samples of the study subjects. Different aliquots of the PCR reaction product were subjected to RFLP analysis for SNP genotyping and detection. We characterized the expression and function of the CD200\u2013CD200R axis and PI3 in celiac disease. A significantly higher level of soluble CD200 and CD200R and lower expression of PI3 in serum of CD patients was observed compared to healthy controls. Consistent with our results, CD200 expression is regulated by IFN-gamma. Interaction of CD200\/CD200R leads to production of type-Th1 and -Th17 cytokines. Regarding the PI3 genotype, the CT genotype proportion SNP rs1733103 and the GG genotype SNP rs41282752 were predominant in CD patients. SNP rs1733103 showed a significant association between the SNP variables and CD. In celiac disease the immune checkpoint is compromised or dysregulated, which can contribute to inflammation and the autoimmunity process. The study of these checkpoint points will lead to the development of targeted therapies aimed at restoring immunological balance in CD. Specific coding regions of the PI3 gene-splice variants predispose the Elafin protein, both at the transcriptional and post-translational levels, to modify its expression and function, resulting in reduced differential functional protein levels in patients with active celiac disease.<\/jats:p>","DOI":"10.3390\/ijms25020852","type":"journal-article","created":{"date-parts":[[2024,1,10]],"date-time":"2024-01-10T07:50:48Z","timestamp":1704873048000},"page":"852","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Expression of Elafin and CD200 as Immune Checkpoint Molecules Involved in Celiac Disease"],"prefix":"10.3390","volume":"25","author":[{"given":"Candelaria","family":"Ponce-de-Le\u00f3n","sequence":"first","affiliation":[{"name":"Department of Experimental Biology, Faculty of Health Sciences, University of Ja\u00e9n, 23071 Ja\u00e9n, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9692-5870","authenticated-orcid":false,"given":"Pedro","family":"Lorite","sequence":"additional","affiliation":[{"name":"Department of Experimental Biology, Faculty of Health Sciences, University of Ja\u00e9n, 23071 Ja\u00e9n, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel \u00c1ngel","family":"L\u00f3pez-Casado","sequence":"additional","affiliation":[{"name":"Department of Pediatric Gastroenterology, Virgen de las Nieves Hospital, 18014 Granada, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7967-3379","authenticated-orcid":false,"given":"Pablo","family":"Mora","sequence":"additional","affiliation":[{"name":"Department of Experimental Biology, Faculty of Health Sciences, University of Ja\u00e9n, 23071 Ja\u00e9n, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7144-4931","authenticated-orcid":false,"given":"Teresa","family":"Palomeque","sequence":"additional","affiliation":[{"name":"Department of Experimental Biology, Faculty of Health Sciences, University of Ja\u00e9n, 23071 Ja\u00e9n, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9309-3837","authenticated-orcid":false,"given":"Mar\u00eda Isabel","family":"Torres","sequence":"additional","affiliation":[{"name":"Department of Experimental Biology, Faculty of Health Sciences, University of Ja\u00e9n, 23071 Ja\u00e9n, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,1,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s00005-018-0520-z","article-title":"Celiac Disease Autoimmunity","volume":"66","author":"Lorite","year":"2018","journal-title":"Arch. Immunol. Ther. Exp."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/nri3407","article-title":"Triggers and drivers of autoimmunity: Lessons from coeliac disease","volume":"13","author":"Sollid","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Chatzidionysiou, K. (2015). Autoimmunity-Pathogenesis, Clinical Aspects and Therapy of Specific Autoimmune Diseases, Intech.","DOI":"10.5772\/58718"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1056\/NEJMcp1113994","article-title":"Clinical practice. Celiac disease","volume":"367","author":"Fasano","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1146\/annurev.immunol.18.1.53","article-title":"Molecular basis of celiac disease","volume":"18","author":"Sollid","year":"2000","journal-title":"Annu. Rev. Immunol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/08916930701619219","article-title":"Autoantibodies in celiac disease","volume":"41","author":"Alaedini","year":"2008","journal-title":"Autoimmunity"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1172\/JCI30253","article-title":"Celiac disease: Pathogenesis of a model immunogenetic disease","volume":"117","author":"Kagnoff","year":"2007","journal-title":"J. Clin. Investig."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1146\/annurev-immunol-040210-092915","article-title":"Integration of genetic and immunological insights into a model of celiac disease pathogenesis","volume":"29","author":"Abadie","year":"2011","journal-title":"Annu. Rev. Immunol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.autrev.2012.01.007","article-title":"The function of tissue transglutaminase in celiac disease","volume":"11","author":"Vanoli","year":"2012","journal-title":"Autoimmun. Rev."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.autrev.2010.06.003","article-title":"Transglutaminase 2-targeted autoantibodies in celiac disease: Pathogenetic players in addition to diagnostic tools?","volume":"9","author":"Lindfors","year":"2010","journal-title":"Autoimmun. Rev."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"34109","DOI":"10.1074\/jbc.M204521200","article-title":"Gliadin T cell epitope selection by tissue transglutaminase in celiac disease. Role of enzyme specificity and pH influence on the transamidation versus deamidation process","volume":"277","author":"Fleckenstein","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s13223-021-00557-y","article-title":"Anti-ganglioside antibodies and celiac disease","volume":"17","author":"Granito","year":"2021","journal-title":"Allergy Asthma Clin. Immunol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/j.1365-2249.2004.02541.x","article-title":"Anti-actin IgA antibodies in severe coeliac disease","volume":"137","author":"Granito","year":"2004","journal-title":"Clin. Exp. Immunol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1084\/jem.191.4.603","article-title":"The intestinal T cell response to alpha-gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase","volume":"191","author":"Molberg","year":"2000","journal-title":"J. Exp. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1053\/j.gastro.2011.11.021","article-title":"T-cell response to gluten in patients with HLA-DQ2.2 reveals requirement of peptide-MHC stability in celiac disease","volume":"142","author":"Bodd","year":"2012","journal-title":"Gastroenterology"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1084\/jem.178.1.187","article-title":"Gliadin-specific, HLA-DQ (alpha 1*0501, beta 1*0201) restricted T cells isolated from the small intestinal mucosa of celiac disease patients","volume":"178","author":"Lundin","year":"1993","journal-title":"J. Exp. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41572-018-0054-z","article-title":"Coeliac disease","volume":"5","author":"Lindfors","year":"2019","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/1423-0127-19-88","article-title":"HLA-DQA1 and HLA-DQB1 in Celiac disease predisposition: Practical implications of the HLA molecular typing","volume":"19","author":"Megiorni","year":"2012","journal-title":"J. Biomed. Sci."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1038\/ni.1780","article-title":"Differences in the risk of celiac disease associated with HLA-DQ2.5 or HLA-DQ2.2 are related to sustained gluten antigen presentation","volume":"10","author":"Fallang","year":"2009","journal-title":"Nat. Immunol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s00281-012-0312-1","article-title":"From genome-wide association studies to disease mechanisms: Celiac disease as a model for autoimmune diseases","volume":"34","author":"Kumar","year":"2012","journal-title":"Semin. Immunopathol."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Zhernakova, A., Stahl, E.A., Trynka, G., Raychaudhuri, S., Festen, E.A., Franke, L., Westra, H.J., Fehrmann, R.S., Kurreeman, F.A., and Thomson, B. (2011). Meta-analysis of genome-wide association studies in celiac disease and rheumatoid arthritis identifies fourteen non-HLA shared loci. PLoS Genet., 7.","DOI":"10.1371\/journal.pgen.1002004"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/ng.102","article-title":"Newly identified genetic risk variants for celiac disease related to the immune response","volume":"40","author":"Hunt","year":"2008","journal-title":"Nat. Genet."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"678400","DOI":"10.3389\/fimmu.2021.678400","article-title":"Significance of PD1 Alternative Splicing in Celiac Disease as a Novel Source for Diagnostic and Therapeutic Target","volume":"12","author":"Lorite","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/s41423-019-0256-7","article-title":"Dysregulation of the PD-1\/PD-L1 pathway contributes to the pathogenesis of celiac disease","volume":"16","author":"Lorite","year":"2019","journal-title":"Cell. Mol. Immunol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1365-2249.2007.03365.x","article-title":"Tryptophan metabolism and indoleamine 2,3-dioxygenase expression in coeliac disease","volume":"148","author":"Torres","year":"2007","journal-title":"Clin. Exp. Immunol."},{"key":"ref_26","first-page":"483","article-title":"CD200 and its receptors as targets for immunoregulation","volume":"65","author":"Gorczynski","year":"2005","journal-title":"Curr. Opin. Investig. Drugs."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1039\/C6TB02269C","article-title":"CD200 modulates macrophage cytokine secretion and phagocytosis in response to poly(lactic co-glycolic acid) microparticles and films","volume":"5","author":"Chen","year":"2017","journal-title":"J. Mater. Chem. B"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Kotwica-Mojzych, K., Jod\u0142owska-J\u0119drych, B., and Mojzych, M. (2021). CD200:CD200R Interactions and Their Importance in Immunoregulation. Int. J. Mol. Sci., 5.","DOI":"10.3390\/ijms22041602"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1159\/000252803","article-title":"Expression of the inhibitory CD200 receptor is associated with alternative macrophage activation","volume":"2","author":"Koning","year":"2010","journal-title":"J. Innat. Immunol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1002\/eji.200425080","article-title":"The CD200 and CD200 receptor cell surface proteins interact through their N-terminal immunoglobulin-like domains","volume":"34","author":"Hatherley","year":"2004","journal-title":"Eur. J. Immunol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/bph.15985","article-title":"Elafin and its precursor trappin-2: What is their therapeutic potential for intestinal diseases?","volume":"180","author":"Deraison","year":"2023","journal-title":"Br. J. Pharmacol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1042\/BST0391450","article-title":"Therapeutic potential of human elafin","volume":"39","author":"Shaw","year":"2011","journal-title":"Biochem. Soc. Trans."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/ajg.2014.48","article-title":"Novel role of the serine protease inhibitor elafin in gluten-related disorders","volume":"109","author":"Galipeau","year":"2014","journal-title":"Am. J. Gastroenterol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/0016-5085(92)91819-P","article-title":"Gluten, major histocompatibility complex, and the small intestine: A molecular and immunobiologic approach to the spectrum of gluten sensitivity (\u2018celiac sprue\u2019)","volume":"102","author":"Marsh","year":"1992","journal-title":"Gastroenterology"},{"key":"ref_35","unstructured":"Torres, M.I., L\u00f3pez Casado, M.A., Palomeque, T., and Lorite, P. (2021). Celiac Disease, IntechOpen."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1093\/intimm\/dxh208","article-title":"Synthetic peptides from the N terminal regions of CD200 and CD200R1 modulate immunosuppressive and anti-inflammatory effects of CD200-CD200R1 interaction","volume":"17","author":"Chen","year":"2005","journal-title":"Int. Immunol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"e741","DOI":"10.1002\/iid3.741","article-title":"The modulation of macrophage subsets in celiac disease pathogenesis","volume":"10","author":"Asri","year":"2022","journal-title":"Immun. Inflamm. Dis."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.clim.2010.01.003","article-title":"Monocytes differentiated with IL-15 support Th17 and Th1 responses to wheat gliadin: Implications for celiac disease","volume":"135","author":"Harris","year":"2010","journal-title":"Clin. Immunol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1189\/jlb.1204712","article-title":"Involvement of CC chemokine ligand 18 (CCL18) in normal and pathological processes","volume":"78","author":"Schutyser","year":"2005","journal-title":"J. Leukoc. Biol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3389\/fnut.2019.00167","article-title":"Intestinal Epithelium Modulates Macrophage Response to Gliadin in Celiac Disease","volume":"5","author":"Serena","year":"2019","journal-title":"Front. Nutr."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nrrheum.2015.53","article-title":"The IL-23-IL-17 axis in inflammatory arthritis","volume":"11","author":"Lubberts","year":"2015","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1002\/ibd.21248","article-title":"IL-23\/IL-17 axis in IBD","volume":"16","author":"Sarra","year":"2010","journal-title":"Inflamm. Bowel. Dis."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"15610","DOI":"10.1021\/bi051418i","article-title":"Elafin and its precursor trappin-2 still inhibit neutrophil serine proteinases when they are covalently bound to extracellular matrix proteins by tissue transglutaminase","volume":"44","author":"Guyot","year":"2005","journal-title":"Biochemistry"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"713540","DOI":"10.3389\/fimmu.2021.713540","article-title":"Alternative Splicing: A New Cause and Potential Therapeutic Target in Autoimmune Disease","volume":"12","author":"Ren","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1093\/bioinformatics\/btl268","article-title":"SNPStats: A web tool for the analysis of association studies","volume":"22","author":"Valls","year":"2006","journal-title":"Bioinformatics"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/2\/852\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T13:43:37Z","timestamp":1760103817000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/2\/852"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,10]]},"references-count":45,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,1]]}},"alternative-id":["ijms25020852"],"URL":"https:\/\/doi.org\/10.3390\/ijms25020852","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,10]]}}}